Viewing Study NCT00113594


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-02-25 @ 6:31 PM
Study NCT ID: NCT00113594
Status: COMPLETED
Last Update Posted: 2007-11-06
First Post: 2005-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module